Pharmacology and pharmacogenetics of chemotherapeutic agents. - Wikidata - awgldk - TriplyDB

Pharmacology and pharmacogenetics of chemotherapeutic agents.

Pharmacology and pharmacogenetics of chemotherapeutic agents.

http://www.wikidata.org/entity/Q37500096

about

Biomarker discovery and clinical proteomics.Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil.Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type.Selective cell cycle arrest and induction of apoptosis in human prostate cancer cells by a polyphenol-rich extract of Solanum nigrum.Safe and effective medicines for all: is personalized medicine the answer?Pharmacogenetic testing in the face of unclear clinical efficacy: lessons from cytochrome P450 2D6 for tamoxifen.

P2860

Q33655101-989F733C-BEE6-4438-A99E-5EE87BDB7E51 Q33683487-C1931B6B-E229-470E-9C8B-472947615837 Q35179761-B26B47BD-72B4-462B-A44D-089FE9A1FE0F Q35833127-68AE6472-FE98-4405-BF39-722D219DFB4C Q36175128-A87C739B-2EEE-4243-973E-D32EFDF0B361 Q37111958-97A8DE40-8152-445B-AE81-4B1EE3A0ED92 Q37694690-8E282B53-A74B-482F-8912-5BD1D03C7CDC Q44483899-02F1E653-F4DA-4C38-8CB5-B9448D2E8507 Q45962136-E82AB207-0D77-479E-9AB3-AF017A66D81D

P2860

Pharmacology and pharmacogenetics of chemotherapeutic agents.

http://www.wikidata.org/entity/Q37500096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@en

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@nl

type

label

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@en

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@nl

prefLabel

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@en

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@nl

P1433

Q37500096-BC90F7D3-3AA4-4FB3-9A6E-6DA5EDD6E58D

P1476

Q37500096-51476BB0-A9DC-4EA8-A08D-2910ED07A366

P2093

Q37500096-DA638B79-5C51-4C33-ABD5-72F6A4D15B0D

Q37500096-EB0D757F-490D-43EC-8986-D1AB2317588F

P2860

Q37500096-16BE3D12-D088-4D06-BDF4-7B41284478BC

Q37500096-304E988E-C216-488C-877C-64041E102FF5

Q37500096-34D08EFC-58E3-4D3B-87EB-D310D7243994

Q37500096-3B82E75C-8CF4-485B-9720-A6339C08C039

Q37500096-408D0EA2-9610-4B04-8E51-67CE8C405DF4

Q37500096-6A4D60A6-21AE-4FEC-B860-503E0F278C09

Q37500096-810A57D2-0AF4-47E8-AEDC-EF587A90CF84

Q37500096-81936FC8-FA4D-4625-BBF0-B58D35D4DF0A

Q37500096-8704DD5A-9ED9-4C10-A3E6-0BD59CE1A54C

Q37500096-8CA6EAA0-B6C5-4EF3-880F-6A7527A314A9

P304

Q37500096-23101CF8-6545-405C-9702-A558FEC16FCD

P31

Q37500096-4E27A297-FA06-4456-BCB8-384C4E33EF2A

P356

Q37500096-628239EE-6736-4B1D-B5A9-587254C4952C

P433

Q37500096-E919DD40-5858-4EA6-B6A2-61E6F3F27CC7

P478

Q37500096-84E6D092-BF40-49AA-AB05-5B09EAFF47D0

P577

Q37500096-1C2E30F1-B71F-4D44-B7EB-27CFFBA5D210

P698

Q37500096-381F202F-0268-4DDB-974D-1D2DD9980D1D

P921

Q37500096-1A9C371F-3135-4E27-968C-B3E8230FD2E8

Q37500096-990C1CCB-4F74-4865-BED9-1F9A89CDB7CC

P356

07357900802574660

P1433

Cancer Investigation

P1476

Pharmacology and pharmacogenetics of chemotherapeutic agents.

@en

P2093

Brian Leyland-Jones

http://www.w3.org/2001/XMLSchema#string

Shaheenah Dawood

http://www.w3.org/2001/XMLSchema#string

P2860

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

Pharmacogenomics: translating functional genomics into rational therapeutics.

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

P304

482-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357900802574660

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19479485

http://www.w3.org/2001/XMLSchema#string

P921